Outlook Therapeutics Files Prospectus Supplement Related To Offer, Sale Of Up To $93.7M Of Common Stock That May Be Sold Under Sales Agreement
Outlook Therapeutics Files Prospectus Supplement Related To Offer, Sale Of Up To $93.7M Of Common Stock That May Be Sold Under Sales Agreement
Outlook Therapeutics提交了與要約和出售高達9,370萬美元的普通股相關的招股說明書補充文件，這些普通股可能根據銷售協議出售
Outlook Therapeutics Files Prospectus Supplement Related To Offer, Sale Of Up To $93.7M Of Common Stock That May Be Sold Under Sales Agreement
Outlook Therapeutics提交了與要約和出售高達9,370萬美元的普通股相關的招股說明書補充文件，這些普通股可能根據銷售協議出售
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。